Xylo Technologies (NASDAQ:XYLO) and Five9 (NASDAQ:FIVN) Critical Analysis

Five9 (NASDAQ:FIVNGet Free Report) and Xylo Technologies (NASDAQ:XYLOGet Free Report) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Volatility & Risk

Five9 has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Xylo Technologies has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Earnings & Valuation

This table compares Five9 and Xylo Technologies”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Five9 $1.04 billion 2.05 -$81.76 million ($0.20) -141.20
Xylo Technologies $57.64 million 0.07 -$16.02 million N/A N/A

Xylo Technologies has lower revenue, but higher earnings than Five9.

Profitability

This table compares Five9 and Xylo Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Five9 -1.23% 3.62% 0.99%
Xylo Technologies N/A N/A N/A

Insider and Institutional Ownership

96.6% of Five9 shares are owned by institutional investors. Comparatively, 0.3% of Xylo Technologies shares are owned by institutional investors. 1.8% of Five9 shares are owned by company insiders. Comparatively, 2.2% of Xylo Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and target prices for Five9 and Xylo Technologies, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Five9 0 5 14 0 2.74
Xylo Technologies 0 0 0 0 0.00

Five9 currently has a consensus price target of $57.65, suggesting a potential upside of 104.13%. Given Five9’s stronger consensus rating and higher possible upside, equities analysts clearly believe Five9 is more favorable than Xylo Technologies.

Summary

Five9 beats Xylo Technologies on 9 of the 12 factors compared between the two stocks.

About Five9

(Get Free Report)

Five9, Inc., together with its subsidiaries, provides intelligent cloud software for contact centers in the United States, India, and internationally. It offers a virtual contact center cloud platform that delivers a suite of applications, which enables the breadth of contact center-related customer service, sales, and marketing functions. The company’s platform comprises of including interactive virtual agent, agent assist, workflow automation, workforce engagement management, AI insights, and AI summaries that allows to manage and optimize customer interactions across voice, chat, email, web, social media, and mobile channels directly or through its application programming interfaces. It also matches each customer interaction with an agent resource and delivers customer data to the agent in real-time through integrations with adjacent enterprise applications, such as CRM software, to optimize the customer experience and enhance agent productivity. The company serves customers in various industries, such as banking and financial services, business process outsourcers, retail, healthcare, technology, and education. Five9, Inc. was incorporated in 2001 and is headquartered in San Ramon, California.

About Xylo Technologies

(Get Free Report)

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Receive News & Ratings for Five9 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Five9 and related companies with MarketBeat.com's FREE daily email newsletter.